BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28628106)

  • 1. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia.
    McGinnis R; Steinthorsdottir V; Williams NO; Thorleifsson G; Shooter S; Hjartardottir S; Bumpstead S; Stefansdottir L; Hildyard L; Sigurdsson JK; Kemp JP; Silva GB; Thomsen LCV; Jääskeläinen T; Kajantie E; Chappell S; Kalsheker N; Moffett A; Hiby S; Lee WK; Padmanabhan S; Simpson NAB; Dolby VA; Staines-Urias E; Engel SM; Haugan A; Trogstad L; Svyatova G; Zakhidova N; Najmutdinova D; ; ; Dominiczak AF; Gjessing HK; Casas JP; Dudbridge F; Walker JJ; Pipkin FB; Thorsteinsdottir U; Geirsson RT; Lawlor DA; Iversen AC; Magnus P; Laivuori H; Stefansson K; Morgan L
    Nat Genet; 2017 Aug; 49(8):1255-1260. PubMed ID: 28628106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.
    Gray KJ; Saxena R; Karumanchi SA
    Am J Obstet Gynecol; 2018 Feb; 218(2):211-218. PubMed ID: 29138037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-allele of rs4769613 Near
    Kikas T; Inno R; Ratnik K; Rull K; Laan M
    Hypertension; 2020 Sep; 76(3):884-891. PubMed ID: 32755415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia.
    Kim SY; Lim JH; Yang JH; Kim MY; Han JY; Ahn HK; Choi JS; Park SY; Kim MJ; Ryu HM
    BMC Med Genet; 2008 Jul; 9():68. PubMed ID: 18631405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intron variant in the FLT1 gene increases the risk of preeclampsia in Iranian women.
    Amin-Beidokhti M; Gholami M; Abedin-Do A; Pirjani R; Sadeghi H; Karamoddin F; Yassaee VR; Mirfakhraie R
    Clin Exp Hypertens; 2019; 41(8):697-701. PubMed ID: 30409050
    [No Abstract]   [Full Text] [Related]  

  • 7. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene.
    Johnson MP; Brennecke SP; East CE; Göring HH; Kent JW; Dyer TD; Said JM; Roten LT; Iversen AC; Abraham LJ; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Laivuori H; ; Austgulen R; Blangero J; Moses EK
    PLoS One; 2012; 7(3):e33666. PubMed ID: 22432041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction.
    Herraiz I; Dröge LA; Gómez-Montes E; Henrich W; Galindo A; Verlohren S
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):265-273. PubMed ID: 25004342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
    Qazi U; Lam C; Karumanchi SA; Petri M
    J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
    Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-Centric Analysis of Preeclampsia Identifies Maternal Association at
    Gray KJ; Kovacheva VP; Mirzakhani H; Bjonnes AC; Almoguera B; DeWan AT; Triche EW; Saftlas AF; Hoh J; Bodian DL; Klein E; Huddleston KC; Ingles SA; Lockwood CJ; Hakonarson H; McElrath TF; Murray JC; Wilson ML; Norwitz ER; Karumanchi SA; Bateman BT; Keating BJ; Saxena R
    Hypertension; 2018 Aug; 72(2):408-416. PubMed ID: 29967039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
    Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
    Tsao PN; Wei SC; Su YN; Chou HC; Chen CY; Hsieh WS
    Pediatrics; 2005 Aug; 116(2):468-72. PubMed ID: 16061605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women.
    Song C; Xie S; Wang J; Lian J; Diao B; Tang Y
    Gynecol Obstet Invest; 2013; 76(1):64-8. PubMed ID: 23860016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.